Huapont Life Sciences exchangeable bonds fully converted, delisting imminent

Huapont Life Sciences Co., Ltd. issued its non-public exchangeable corporate bonds, "25 Huapont EB," to professional investors in April 2025. The bonds, with an issue size of 600 million yuan and a three-year term, were exchangeable for A-shares of Shandong Kailsheng New Material Co., Ltd.

As of the current announcement, all "25 Huapont EB" exchangeable bonds have been fully converted, leaving a zero balance of bonds. Consequently, these exchangeable corporate bonds are scheduled to be delisted from the Shenzhen Stock Exchange on December 8, 2025.

Following the share conversion, Huapont Life Sciences now holds 126,755,153 shares of Kailsheng New Material, representing 30.13% of its total share capital. This conversion does not impact the company's status as the controlling shareholder of Kailsheng New Material.